Stock Track | UnitedHealth Soars 5.03% Intraday on Analyst Upgrades from BofA and Morgan Stanley
Stock Track
Jun 04
UnitedHealth's stock soared 5.03% during intraday trading on Thursday, following a series of bullish analyst actions that boosted investor sentiment.
The surge was primarily driven by BofA Securities upgrading UnitedHealth from Neutral to Buy and raising its price target to $450 from $420. Additionally, Morgan Stanley increased its price target on the stock to $453 from $395 while maintaining an Overweight rating.
These analyst upgrades reflect growing confidence in UnitedHealth's prospects and contributed to the significant price appreciation during the trading session as investors responded to the improved outlook from major financial institutions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.